3,4-dihydroxyphenylglycol has been researched along with ADDH in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hing, J; Hopkins, SC; Koblan, KS; Loebel, A; Passarell, JA; Skende, E; Sunkaraneni, S | 1 |
| Alda, JÁ; Artigas, J; Cardo, E; Escobar, R; García, M; García-Polavieja, MJ; Gastaminza, X; Gilaberte, I; Lachno, DR; Montoya, A | 1 |
| Bernardi, G; Castelli, M; Centonze, D; De Chiara, V; Federici, M; Gu, HH; Mercuri, NB; Motta, C; Musella, A; Napolitano, F; Romano, R; Rossi, S; Sacchetti, L; Siracusano, A; Studer, V; Usiello, A | 1 |
| Hanna, GL; Hariharan, M; Ornitz, EM | 1 |
1 trial(s) available for 3,4-dihydroxyphenylglycol and ADDH
| Article | Year |
|---|---|
Changes of urine dihydroxyphenylglycol to norepinephrine ratio in children with attention-deficit hyperactivity disorder (ADHD) treated with atomoxetine.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Female; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Pilot Projects; Propylamines; Treatment Outcome | 2011 |
3 other study(ies) available for 3,4-dihydroxyphenylglycol and ADDH
| Article | Year |
|---|---|
Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.
Topics: 1-Naphthylamine; Administration, Oral; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dopamine Uptake Inhibitors; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Models, Biological; Norepinephrine Plasma Membrane Transport Proteins; Randomized Controlled Trials as Topic | 2016 |
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dronabinol; Excitatory Amino Acid Antagonists; Food Preferences; Gene Expression Regulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Point Mutation; Receptor, Cannabinoid, CB1; Receptors, GABA-B; Sucrose | 2011 |
Urinary catecholamine excretion and behavioral differences in ADHD and normal boys.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Catecholamines; Child; Child Behavior; Dihydroxyphenylalanine; Dopamine; Epinephrine; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Reflex, Startle | 1996 |